Samuel Davis

19.3k total citations · 10 hit papers
35 papers, 15.5k citations indexed

About

Samuel Davis is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Samuel Davis has authored 35 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Samuel Davis's work include Angiogenesis and VEGF in Cancer (10 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Lipid metabolism and disorders (4 papers). Samuel Davis is often cited by papers focused on Angiogenesis and VEGF in Cancer (10 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Lipid metabolism and disorders (4 papers). Samuel Davis collaborates with scholars based in United States, Japan and Canada. Samuel Davis's co-authors include George D. Yancopoulos, Stanley J. Wiegand, Peter C. Maisonpierre, Thomas H. Aldrich, Pamela F. Jones, Nicholas W. Gale, Jocelyn Holash, John S. Rudge, Chitra Suri and Czeslaw Radziejewski and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Samuel Davis

33 papers receiving 15.1k citations

Hit Papers

Vascular-specific growth factors and blood vessel formation 1991 2026 2002 2014 2000 1997 1996 1996 1996 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vascular-specific growth factors and blood vessel formation
    2000 3.0k citations George D. Yancopoulos, Samuel Davis et al. Nature profile →
  2. Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
    1997 2.8k citations Peter C. Maisonpierre, Chitra Suri et al. Science profile →
  3. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
    1996 2.3k citations Chitra Suri, Pamela F. Jones et al. Cell profile →
  4. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
    1996 1.6k citations Samuel Davis, Thomas H. Aldrich et al. Cell profile →
  5. Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis
    1996 731 citations Nicholas W. Gale, Sacha J. Holland et al. Neuron profile →
  6. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor
    1991 722 citations Stephen P. Squinto, Trevor N. Stitt et al. Cell profile →
  7. Ligands for EPH-Related Receptor Tyrosine Kinases that Require Membrane Attachment or Clustering for Activity
    1994 610 citations Samuel Davis, Nicholas W. Gale et al. Science profile →
  8. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130
    1992 593 citations Nancy Y. Ip, Samuel Davis et al. Cell profile →
  9. LIFRβ and gp130 as Heterodimerizing Signal Transducers of the Tripartite CNTF Receptor
    1993 556 citations Samuel Davis, Thomas H. Aldrich et al. Science profile →
  10. The Receptor for Ciliary Neurotrophic Factor
    1991 516 citations Samuel Davis, Thomas H. Aldrich et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Davis United States 25 10.1k 3.4k 3.0k 2.8k 1.9k 35 15.5k
Peter C. Maisonpierre United States 21 9.6k 1.0× 3.7k 1.1× 2.0k 0.7× 3.1k 1.1× 2.2k 1.2× 26 14.2k
Lieve Moons Belgium 62 9.9k 1.0× 2.1k 0.6× 2.6k 0.9× 5.5k 2.0× 1.2k 0.6× 270 19.5k
Nicholas W. Gale United States 44 11.6k 1.1× 6.3k 1.8× 3.3k 1.1× 2.0k 0.7× 864 0.5× 67 18.0k
Jack Lawler United States 77 11.8k 1.2× 2.1k 0.6× 2.9k 1.0× 4.7k 1.7× 966 0.5× 206 20.2k
Czeslaw Radziejewski United States 26 6.6k 0.7× 2.0k 0.6× 1.9k 0.6× 1.7k 0.6× 1.1k 0.6× 39 10.5k
William B. Stallcup United States 63 6.8k 0.7× 2.6k 0.8× 1.4k 0.5× 1.8k 0.6× 697 0.4× 146 13.0k
Ralf H. Adams Germany 82 14.9k 1.5× 4.9k 1.4× 4.3k 1.4× 3.0k 1.1× 1.0k 0.6× 212 25.8k
Karl H. Plate Germany 68 10.8k 1.1× 1.4k 0.4× 3.1k 1.0× 6.0k 2.1× 651 0.3× 159 17.1k
Thomas H. Aldrich United States 15 5.7k 0.6× 2.1k 0.6× 1.6k 0.6× 1.5k 0.5× 1.2k 0.6× 17 8.7k
John S. Rudge United States 38 6.4k 0.6× 1.7k 0.5× 1.8k 0.6× 1.9k 0.7× 879 0.5× 57 10.9k

Countries citing papers authored by Samuel Davis

Since Specialization
Citations

This map shows the geographic impact of Samuel Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Davis more than expected).

Fields of papers citing papers by Samuel Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Davis. The network helps show where Samuel Davis may publish in the future.

Co-authorship network of co-authors of Samuel Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Davis. A scholar is included among the top collaborators of Samuel Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Davis. Samuel Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Samuel, et al.. (2024). A Scoping Review on the Management of Open Fractures in African Trauma and Orthopaedics Centres. Cureus. 16(9). e68925–e68925.
2.
Davis, Samuel, et al.. (2023). 1119 A Scoping Review of Kidney Transplantation in Africa: How Far Have We Come?. British journal of surgery. 110(Supplement_7). 1 indexed citations
3.
Davis, Samuel, et al.. (2022). A Scoping Review of the Management of Benign Prostate Hyperplasia in Africa. Cureus. 14(11). e31135–e31135. 1 indexed citations
4.
Daly, Christopher, Xiaozhong Qian, Carla Castanaro, et al.. (2018). Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. Scientific Reports. 8(1). 505–505. 36 indexed citations
5.
Smith, Eric, Kara Olson, Lauric Haber, et al.. (2015). A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Scientific Reports. 5(1). 17943–17943. 122 indexed citations
6.
Bertrand, Thomas, A. Dupuy, Alexey Rak, et al.. (2012). The Crystal Structures of TrkA and TrkB Suggest Key Regions for Achieving Selective Inhibition. Journal of Molecular Biology. 423(3). 439–453. 87 indexed citations
7.
Leppla, Stephen H., Shihui Liu, Thomas Bugge, et al.. (2009). Matrix Metalloproteinase–Activated Anthrax Lethal Toxin Inhibits Endothelial Invasion and Neovasculature Formation during In vitro Morphogenesis. Molecular Cancer Research. 7(4). 452–461. 16 indexed citations
8.
Rudge, J.S., Gavin Thurston, Samuel Davis, et al.. (2005). VEGF Trap as a Novel Antiangiogenic Treatment Currently in Clinical Trials for Cancer and Eye Diseases, and VelociGene(R)- based Discovery of the Next Generation of Angiogenesis Targets. Cold Spring Harbor Symposia on Quantitative Biology. 70(0). 411–418. 38 indexed citations
9.
Gale, Nicholas W., Gavin Thurston, Samuel Davis, et al.. (2002). Complementary and Coordinated Roles of the VEGFs and Angiopoietins during Normal and Pathologic Vascular Formation. Cold Spring Harbor Symposia on Quantitative Biology. 67(0). 267–274. 37 indexed citations
10.
Yancopoulos, George D., Samuel Davis, Nicholas W. Gale, et al.. (2000). Vascular-specific growth factors and blood vessel formation. Nature. 407(6801). 242–248. 3010 indexed citations breakdown →
11.
Davis, Samuel & George D. Yancopoulos. (1999). The Angiopoietins: Yin and Yang in Angiogenesis. Current topics in microbiology and immunology. 237. 173–185. 153 indexed citations
12.
Maisonpierre, Peter C., Chitra Suri, Pamela F. Jones, et al.. (1997). Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis. Science. 277(5322). 55–60. 2842 indexed citations breakdown →
13.
Davis, Samuel, Thomas H. Aldrich, Pamela F. Jones, et al.. (1996). Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning. Cell. 87(7). 1161–1169. 1595 indexed citations breakdown →
14.
Suri, Chitra, Pamela F. Jones, Sybill Patan, et al.. (1996). Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis. Cell. 87(7). 1171–1180. 2280 indexed citations breakdown →
15.
Gale, Nicholas W., Sacha J. Holland, David M. Valenzuela, et al.. (1996). Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis. Neuron. 17(1). 9–19. 731 indexed citations breakdown →
16.
Stahl, Neil, Samuel Davis, Vivien Wong, et al.. (1993). Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component.. Journal of Biological Chemistry. 268(11). 7628–7631. 82 indexed citations
17.
Ip, Nancy Y., Joyce McClain, Nestor X. Barrezueta, et al.. (1993). The α component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development. Neuron. 10(1). 89–102. 350 indexed citations
18.
Davis, Samuel & George D. Yancopoulos. (1993). The molecular biology of the CNTF receptor. Current Opinion in Neurobiology. 3(1). 20–24. 48 indexed citations
19.
Davis, Samuel, Thomas H. Aldrich, Nancy Y. Ip, et al.. (1993). Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses. Science. 259(5102). 1736–1739. 309 indexed citations
20.
Squinto, Stephen P., Trevor N. Stitt, Thomas H. Aldrich, et al.. (1991). trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell. 65(5). 885–893. 722 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter C. Maisonpierre Breakdown of academic impact, for papers by Lieve Moons Breakdown of academic impact, for papers by Nicholas W. Gale Breakdown of academic impact, for papers by Jack Lawler Breakdown of academic impact, for papers by Czeslaw Radziejewski Breakdown of academic impact, for papers by William B. Stallcup Breakdown of academic impact, for papers by Ralf H. Adams Breakdown of academic impact, for papers by Karl H. Plate Breakdown of academic impact, for papers by Thomas H. Aldrich Breakdown of academic impact, for papers by John S. Rudge
Rankless by CCL
2026